Moleculin Biotech, Inc. MBRX
- WP1066 — Glioblastoma Phase 2
- WP1066 — Pediatric Brain Tumors
- WP1066 — Glioblastoma Preclinical
STAT3 (1 companies · 3 programs)
Companies with an active program directed at STAT3.
Companies with an active program directed at STAT3.